Format

Send to

Choose Destination
Climacteric. 2016 Aug;19(4):387-92. doi: 10.1080/13697137.2016.1191460. Epub 2016 Jun 21.

Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?

Author information

1
a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) ;
2
b Departamento de Medicina Interna Sur, Facultad de Medicina , Universidad de Chile , Santiago de Chile , Chile ;
3
c Institute of Biomedicine, Research Area for Women's Health, Facultad de Ciencias Médicas , Universidad Católica de Santiago de Guayaquil , Guayaquil , Ecuador.

Abstract

OBJECTIVE:

To evaluate whether menopausal status and symptoms among female gynecologists would influence their clinical behavior related to menopausal hormone therapy (MHT).

METHODS:

Female gynecologists of 11 Latin American countries were requested to fill out the Menopause Rating Scale and a questionnaire containing personal information and that related to MHT use.

RESULTS:

A total of 818 gynecologists accepted to participate (86.4%). Overall, the mean age was 45.0 ± 10.7 years, 32.2% were postmenopausal, and 17.6% worked in an academic position; 81.8% reported that they would use MHT if they have symptoms, regardless of menopausal status. Academic gynecologists favor personal MHT use at a higher rate (p = 0.04) and have a higher MHT prescription rate as compared to non-academic ones (p = 0.0001). The same trend was observed among post- as compared to premenopausal ones (p = 0.01) and among those who had hysterectomy alone as compared to those experiencing natural menopause (p = 0.002). The presence of menopausal symptoms did not influence their MHT prescription. Current use of MHT and alternative therapy was higher among post- than premenopausal gynecologists (both, p = 0.0001) and among those who had undergone hysterectomy than those experiencing natural menopause. A 38.5% perceived breast cancer as the main risk related to MHT, and a high proportion prescribed non-hormonal drugs (86.4%) or alternative therapies (84.5%).

CONCLUSION:

Most female gynecologists in this survey would use MHT if menopausal symptoms were present. Postmenopausal physicians use MHT and prescribe it to their symptomatic patients at a higher rate than premenopausal physicians.

KEYWORDS:

Beliefs; female gynecologists; menopausal hormone therapy; perceptions; prescription

PMID:
27327136
DOI:
10.1080/13697137.2016.1191460
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center